@article{costa:hal-01427005,
TITLE = {Pegylated interferon $\alpha$-2a triggers NK-cell functionality and specific T-cell responses in patients with chronic HBV infection without HBsAg seroconversion},
AUTHOR = {Costa, J.B. and Dufeu-Duchesne, T. and Leroy, V. and Bertucci, I. and Bouvier-Alias, M. and Pouget, N. and Brevot-Lutton, O. and Bourli{\`e}re, M. and Zoulim, F. and Plumas, J. and Aspord, C.},
URL = {https://univ-rennes.hal.science/hal-01427005},
JOURNAL = {PLoS ONE},
PUBLISHER = {Public Library of Science},
VOLUME = {11},
NUMBER = {6},
PAGES = {e0158297},
YEAR = {2016},
DOI = {10.1371/journal.pone.0158297},
KEYWORDS = { chronic hepatitis B ; clinical article ; CD4+ T lymphocyte ; Article ; dendritic cell ; controlled study ; drug mechanism ; evolution ; cellular immunity ; cell activation ; CD8+ T lymphocyte ; human ; human cell ; peginterferon alpha2a ; adaptive immunity ; nucleoside analog ; hepatitis B surface antigen ; lymphocyte function ; innate immunity ; multicenter study (topic) ; phase 3 clinical trial (topic) ; natural killer cell ; randomized controlled trial (topic) ; phenotype ; seroconversion ; T lymphocyte},
HAL_ID = {hal-01427005},
HAL_VERSION = {v1},
}